Biotechnology

Jasper Therapeutics

BTIG Analyst Reiterates Buy Rating for Jasper Therapeutics

Jasper Therapeutics released FY2025 9 Months earnings on November 10 (EST), actual revenue USD 0, actual EPS USD -4.2829

Jasper Therapeutics released FY2025 Q3 earnings on November 10 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -1.1262 (forecast USD -1.2144)

TD Cowen Maintains Buy Rating on Jasper Therapeutics

Jasper Therapeutics released FY2025 Semi-Annual earnings on August 13 (EST), actual revenue USD 0, actual EPS USD -3.1599

Jasper Therapeutics released FY2025 Q2 earnings on August 13 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -1.7427 (forecast USD -1.3434)

Jasper Therapeutics Releases Second Quarter 2025 Financials

Jasper Therapeutics Holds Annual Shareholders Meeting to Elect Directors

Jasper Therapeutics Inc. Reports Clinical Progress of Briquilimab

Jasper Therapeutics Inc. Reports Positive Results for Chronic Urticaria Drug Study

Jasper Therapeutics to Present Briquilimab Data at 2025 EAACI Congress

Jasper Therapeutics Reveals Clinical Efficacy of Briquilimab in Mast Cell-mediated Diseases

Jasper Therapeutics Announces Plans for New Antibody Therapy

Jasper Therapeutics released FY2025 Q1 earnings on May 12 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -1.4139 (forecast USD -1.3811)

Jasper Therapeutics to Release Q1 2025 Earnings Report

Jasper Therapeutics Inc submits a common stock offering application of up to $100 million

Jasper Therapeutics Inc terminates sales agreement with Cantor

Jasper Therapeutics released FY2024 Q4 earnings on February 27 (EST), actual revenue 0 USD (forecast 0 USD), actual EPS -1.6204 USD (forecast -1.254 USD)

Jasper Therapeutics released FY2024 annual earnings on February 27 (EST), actual revenue 0 USD (forecast 0 USD), actual EPS -4.8865 USD (forecast -4.5547 USD)

Jasper Therapeutics Launches New Antibody Therapy briquilimab

Mega Fortune

Processa Pharmaceuticals

cbdMD

Agape ATP

VYNE Therapeutics

Andersen

Inspirato

Medline Inc.

Creative Global Tech

GCI LIBERTY INC COM USD0.01 SER C SUBS RTS 17/12/2025

Please note that a "Suspected value trap" is a stock that appears The stock looks financially sound and severely undervalued, but behind the low valuation is a long-term decline in business capacity or a serious financial crisis, or even the risk of bankruptcy in the short term.

Suspected value trap